Coherent Market Insights Pvt Ltd

Constipation Treatment Market - Global Industry Insights, Trends and Opportunity Analysis, 2016–2024

Press Release   •   Feb 02, 2017 01:58 EST

Constipation Treatment Market Overview

Constipation is a disorder that causes issues related to clearing of the bowels and usually leads to hardened feces. It is especially prevalent among the elderly and women. Common symptoms of constipation include lumpy or hard stools, lower abdominal discomfort, straining to have bowel movements, feeling of blockage in rectum that prevents bowel movements, and infrequent bowel movements. Factor that can lead to constipation are aging, dehydration, little or no physical activity, diet low in fiber, and mental conditions such as depression or eating disorder. Constipation treatment starts with lifestyle and change in diet to increase the speed at which stool moves through intestines. If it doesn’t help then the physician recommend medications or surgery. Lifestyle and diet change includes increase in fiber intake and physical activities such as exercise to increase intestinal muscle activities.

Get the free sample report @ https://www.coherentmarketinsights.com/ongoing-insight/toc/95

Segmentation of Constipation Treatment Market

Constipation treatment market is segmented on the basis of type, treatment, method of administration, and end use. By type, the global constipation treatment market has been categorized into chronic idiopathic constipation (CIC), irritable bowel syndrome with constipation (IBS-C), and opioid-induced constipation (OIC). On the basis of treatment, the global constipation treatment market has been categorized into pharmacological treatment and non-pharmacological treatment, which comprises bowel training for constipation relief, fluid intake, dietary fiber intake and regular exercise. Further, pharmacological treatment is categorized into bulk-forming agents, stool softeners and emollients, osmotic agents, stimulants such as Bisacodyl, castor oil, senna and Cascara Sagrada, and chloride channel activators. On the basis of method of administration, the global constipation treatment market is categorized into oral and parenteral (subcutaneous injection). On the basis of distribution, the global constipation treatment market is segmented into hospital pharmacies, drug stores, and independent pharmacies.

High prevalence rate in North America drive growth of the Constipation Treatment Market

High prevalence rate in North America due to increasing adoption of unhealthy lifestyle characterized by growing consumption of fast food is leading to increasing obesity and other related health issues. This inadvertently leads to high incidence rate of constipation in the region.

View the full research report @ https://www.coherentmarketinsights.com/ongoing-insight/constipation-treatment-market-95

According to the American Society of Interventional Pain Physicians, the U.S. accounts for around 80% of the global opioids consumption. According to an article published in the American Gastroenterological Association in May 2015, chronic constipation affects one in six people in the U.S. and is the third-leading symptom prompting outpatient clinic visits in the country. It is especially prevalent in overweight women. High acuity information system, high disposable income level, and rampant adoption of unhealthy lifestyle in Europe makes it a potential high growth market. Asia Pacific too is expected to be a lucrative market for constipation treatment, mainly due to increasing westernization characterized by rising adoption of non-nutritious fast food in the region.

Global players engaged in the constipation treatment market

The major players operating in constipation treatment market include AstraZeneca plc, Takeda Pharmaceutical Company Limited, Abbott Laboratories, Valeant Pharmaceuticals International, Inc., C.B. Fleet Company Inc., Daewoong Co. Ltd., Sucampo Pharmaceuticals Inc., Cosmo Pharmaceuticals, Synergy Pharmaceuticals Inc. Boehringer Ingelheim GmbH, and Ironwood Pharmaceuticals.

ABOUT COHERENT

COMPANY OVERVIEW

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. Our global team of over 100 research analysts and freelance consultants provide market intelligence from the very molecular country level and also provide a global perspective of the market. Our team is of the most vital cog in our robust machinery that gives us the ability to deliver independent insight relying on our cognitive defusion training module.This allows for an objective and unbiased assessment of the market. We pride ourselves in my constantly striving to update our extremely in-depth understanding of the market by closely monitoring and analyzing markets, trends, and emerging best practices, across allfathomable industries under the sun. This enables us to equip our valued clientele with key decisive inputs to capitalize on lucrative growth opportunities in the market and to follow firmly position themselves on a high growth path in the future.

CONTACT US

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel No: (+1)206-701-6702

sales@coherentmarketinsights.com

Visit Blog: http://healthcaremarketconsulting.blogspot.in/